Are You a North American Company Seeking Regulatory Approval in Europe? A Few Tips from the BIO International Convention for Attaining Drug Approval in this Challenging Regulatory Environment

 

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This study provides an overview of the recent BIO Convention held in Washington DC, between 25 and 30 June 2011, that was attended by Frost & Sullivan. Included are highlights of information presented during the conference. Content includes information regarding the European clinical trial directive, drug approval process, pricing and reimbursement, as well as recommendations and implications.

Table of Contents

Are You a North American Company Seeking Regulatory Approval in Europe? A Few Tips from the BIO International Convention for Attaining Drug Approval in this Challenging Regulatory EnvironmentAnalysis from the BIO International ConventionA Few Tips from the BIO International Convention




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.